Medicare Expands GLP-1 Medication Access Starting July 1
Eligible Medicare beneficiaries may access certain GLP-1 medications for about $50 per month through a new, temporary program.
Running from July 1, 2026, through Dec. 31, 2027, the program has specific eligibility requirements that professionals supporting older adults must understand to guide access to this benefit.
On May 18, the U.S. Supreme Court upheld Medicare’s authority to negotiate drug prices under the Inflation Reduction Act. The ruling lowers prescription costs and strengthens access to medications across the program.
Local falls data helps target high-risk areas, support funding requests, and improve program impact. Learn how to gather, analyze, and apply data from partners like hospitals, EMS, and health departments.
Take part in this annual global call to confront the impact of abuse and ageism on older adults and to help people recognize the signs and respond. Spread the word with tools and resources to engage your community, involve new voices, and help prevent abuse.
Anyone can be a target of fraud. NCOA CEO Ramsey Alwin recently shared guidance on NBC News to help us all recognize red flags, protect personal information, and guide others in reporting fraud.
Medicare Fraud Prevention Starts Early: Preventing Medicare fraud is the most effective way to protect against it. Learn how to spot warning signs of fraud, errors, and abuse—and share these tips across your network.
Genetic Testing Scams Are Rising: Scammers are targeting older adults with “free” genetic tests while stealing Medicare information or billing for unnecessary services. Know how these schemes work and how to stop them.
Understanding Alzheimer’s Disease: Alzheimer’s is the most common form of dementia, affecting memory, behavior, and daily functioning. Build a clearer understanding of symptoms, progression, and treatment options.
